17 July 2024 : Clinical Research
Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study
Qunxian Rao1BCE, Miaoling Huang1B, Meimei Guan1C, Changhao Liu1D, Lijuan Wang1D, Zhongqiu Lin1A*, Qing Chen1ADOI: 10.12659/MSM.943170
Med Sci Monit 2024; 30:e943170
Figure 1 Representative mIF images of pre- and post-NACT samples in patients with benefit or partial benefit.(A) Representative mIF images in patients with benefit; (B) representative mIF images in patients with part benefit. Magnification: ×200. Panoramic (PANO)-1 images show the staining of PD-1 (green), PD-L1 (yellow), CD3 (indigo), CD8 (red), panCK (purple), and DAPI (blue). PANO-2 images show the staining of CD163 (red), CD68 (green), and CD56 (yellow), panCK (purple), and DAPI (blue). mIF – multiplex immunofluorescence; NACT – neoadjuvant chemotherapy. Figure 1 was created by Microsoft PowerPoint software (www.microsoft.com).